Delivery Order SPE2DE21D7020-SPE2D626F5723
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division, effective October 24, 2025, with an ultimate completion date of October 31, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing single-award...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $4,235.60 by the Defense Health Agency's Medical Supply Chain division. The delivery order, issued on October 29, 2025, with an ultimate completion date of November 5, 2025, is characterized by fixed-price pricing with economic price adjustment terms. This award represents a task order issued against Boston Scientific's single-award Blanket Purchase Agreement with the Defense Health...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,580.66 by the Defense Health Agency's Medical Supply Chain division on October 24, 2025. The contract, designated as a fixed-price agreement with economic price adjustment provisions, is scheduled for completion by October 31, 2025. This delivery order is issued without a small business set-aside, allowing Boston Scientific to compete on an...
- Boston Scientific Corp has been awarded a delivery order valued at $1,295.63 under a Defense Health Agency Medical Supply Chain Blanket Purchase Agreement, with a completion deadline of November 7, 2025. This fixed-price contract with economic price adjustment authority represents delivery order activity against Boston Scientific's established single-award BPA with the Defense Health Agency, valued at $750,000 and effective through March 30, 2030. The contract, which carries no small business...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $23,100 fixed-price delivery order with economic price adjustment authority by the Defense Health Agency's Medical Supply Chain division. The contract, designated as delivery order 4569858281 against the company's existing Blanket Purchase Agreement, is scheduled for completion by November 4, 2025. This delivery order represents Boston Scientific's continued role as a critical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $29,701.08 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by October 23, 2025, and represents work to be performed at the contractor's facility in Marlborough, MA. The award was issued without small business set-aside provisions, allowing...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $14,856.64 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment capability is set to be completed by November 10, 2025, and represents a delivery order against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency. The contract involves the provision of specialized medical devices and...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,104.60 under a Blanket Purchase Agreement with the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as 4569783311 NC EMERGE MR 15MM, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 28, 2025. The award was issued without a small business set-aside, allowing...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,688.80 by the Defense Health Agency's Medical Supply Chain division on September 29, 2023, with an ultimate completion date of October 6, 2023. This fixed-price delivery order with economic price adjustment was issued against an established Blanket Purchase Agreement (BPA) and carries no small business set-aside designation. The contract represents Boston Scientific's continued role...
- Boston Scientific Corp has been awarded a $1,577.02 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of November 4, 2025. This delivery order, issued without small business set-aside, represents work performed at the contractor's Marlborough, Massachusetts facility. The award is issued under Boston Scientific's existing single-award Blanket Purchase Agreement with the Defense Health Agency,...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F5723Delivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $4,048 delivery order by the Defense Health Agency's Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 4, 2025. This delivery order operates under a fixed-price contract with economic price adjustment terms and is issued against a larger single-award Blanket Purchase Agreement valued at $750,000, which designates Boston Scientific as the sole supplier for radiation treatment devices through March 30, 2030. The contract does not utilize a small business set-aside, allowing unrestricted competition. The delivery order fulfills the Defense Health Agency's specialized procurement needs for radiation oncology equipment and related technologies supporting military healthcare facilities and Veterans Affairs medical centers. As a critical supplier within the federal healthcare enterprise, Boston Scientific leverages its extensive portfolio of advanced medical devices to support the Department of Defense and Department of Veterans Affairs missions. The company's role as the sole supplier under this blanket purchase agreement for radiation treatment modalities—including yttrium-90 glass microspheres and radiopharmaceuticals—reflects federal government confidence in Boston Scientific's capability to maintain supply chain continuity for complex cancer treatment technologies. This delivery order represents routine resupply operations under the established indefinite delivery vehicle, enabling rapid procurement of specialized radiation treatment devices essential to defense and veterans healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 10/28/25 |